« previous next »
Pages: [1]

Author Topic: Association between weight-loss drugs and MS  (Read 39 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9842
  • MS diagnosed 1980
  • Location: Pacific Northwest
Association between weight-loss drugs and MS
« on: April 09, 2024, 09:38:20 pm »

These researchers (and one of them, O. Stuve, is well known in MS research) are proposing re-purposing several anti-obesity drugs for MS.

From Therapeutic Advances in Neurological Disorders (April 4, 2024)--"Exploring the association between weight-loss inducing medications and multiple sclerosis: Insights from the FDA adverse event reporting system database":


https://journals.sagepub.com/doi/10.1177/17562864241241383#tab-contributors
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
0 Replies
84 Views 		Last post February 27, 2019, 08:05:27 pm
by agate
0 Replies
70 Views 		Last post November 03, 2020, 08:10:23 pm
by agate
0 Replies
28 Views 		Last post June 16, 2022, 09:20:56 pm
by agate
0 Replies
22 Views 		Last post April 27, 2023, 08:41:37 pm
by agate
0 Replies
1635 Views 		Last post November 16, 2023, 09:21:01 pm
by agate